The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study

Treatment decisions for advanced melanoma are increasingly complex and guidelines provide limited advice on how to choose between immunotherapy and targeted therapy for first-line treatment. A Delphi study was carried out to understand which patient characteristics and disease-related factors inform...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascierto, Paolo A., Bastholt, Lars, Ferrucci, Pier F., Hansson, Johan, Márquez Rodas, Iván, Payne, Miranda, Robert, Caroline, Thomas, Luc, Utikal, Jochen S., Wolter, Pascal, Kudlac, Amber, Tuson, Harriet, McKendrick, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
ORIGINAL ARTICLES: Clinical research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039416/
https://www.ncbi.nlm.nih.gov/pubmed/29750751
http://dx.doi.org/10.1097/CMR.0000000000000455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039416/
https://www.ncbi.nlm.nih.gov/pubmed/29750751
http://dx.doi.org/10.1097/CMR.0000000000000455

Ejemplares similares